153 related articles for article (PubMed ID: 20037813)
1. Protective effect of sulodexide on podocyte injury in adriamycin nephropathy rats.
Chen S; Fang Z; Zhu Z; Deng A; Liu J; Zhang C
J Huazhong Univ Sci Technolog Med Sci; 2009 Dec; 29(6):715-9. PubMed ID: 20037813
[TBL] [Abstract][Full Text] [Related]
2. [Effect of Qufeng Tongluo Recipe on expression of desmin and CD2AP proteins in adriamycin-induced nephropathy rats: an experimental research].
Wang Z; Liu JT; Sun WS; Li RP; Wang Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Feb; 34(2):203-8. PubMed ID: 24672946
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of eplerenone on podocyte injury in adriamycin nephropathy rats.
Fang Z; Zhang C; He F; Chen S; Sun X; Zhu Z; Liu J; Meng X
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):329. PubMed ID: 21671173
[TBL] [Abstract][Full Text] [Related]
4. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
5. Treatment with irbesatan may improve slit diaphragm alterations in rats with adriamycin-induced nephropathy.
Wang N; Wei RB; Li P; Li QP; Yang X; Yang Y; Huang MJ; Wang R; Yin Z; Lv Y; Chen XM
J Renin Angiotensin Aldosterone Syst; 2016; 17(2):1470320316646884. PubMed ID: 27169889
[TBL] [Abstract][Full Text] [Related]
6. Effects of asiaticoside on levels of podocyte cytoskeletal proteins and renal slit diaphragm proteins in adriamycin-induced rat nephropathy.
Wang Z; Liu J; Sun W
Life Sci; 2013 Sep; 93(8):352-8. PubMed ID: 23871990
[TBL] [Abstract][Full Text] [Related]
7. Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy.
Rossini M; Naito T; Yang H; Freeman M; Donnert E; Ma LJ; Dunn SR; Sharma K; Fogo AB
Nephrol Dial Transplant; 2010 Jun; 25(6):1803-10. PubMed ID: 20061322
[TBL] [Abstract][Full Text] [Related]
8. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
[TBL] [Abstract][Full Text] [Related]
9. Effect of yiqiyangyin recipe on heparanase and nephrin in rats with adriamycin-induced nephropathy.
Sun W; He Y; Yu J; Lin Y; Wang Y; Gao X; Wang Y; Zhao Z; Liu X
J Tradit Chin Med; 2013 Jun; 33(3):334-42. PubMed ID: 24024329
[TBL] [Abstract][Full Text] [Related]
10. Sulodexide Protects Contrast-Induced Nephropathy in Sprague-Dawley Rats.
Zhao Q; Yin J; Lu Z; Kong Y; Zhang G; Zhao B; Wang F
Cell Physiol Biochem; 2016; 40(3-4):621-632. PubMed ID: 27898408
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
[TBL] [Abstract][Full Text] [Related]
12. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J
Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930
[TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy.
Xie K; Xu C; Zhang M; Wang M; Min L; Qian C; Wang Q; Ni Z; Mou S; Dai H; Pang H; Gu L
Cell Death Dis; 2019 Dec; 10(12):915. PubMed ID: 31801948
[TBL] [Abstract][Full Text] [Related]
14. Diversities of podocyte molecular changes induced by different antiproteinuria drugs.
Xing Y; Ding J; Fan Q; Guan N
Exp Biol Med (Maywood); 2006 May; 231(5):585-93. PubMed ID: 16636307
[TBL] [Abstract][Full Text] [Related]
15. [Gene expressions of xylosyltransferase and heparanase in renal tissue of rat with adriamycin nephropathy and relevance for proteinuria].
Luo W; Wang Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):965-8. PubMed ID: 18095597
[TBL] [Abstract][Full Text] [Related]
16. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
[TBL] [Abstract][Full Text] [Related]
17. Protective role of cyclosporine A and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin.
Guan N; Ren YL; Liu XY; Zhang Y; Pei P; Zhu SN; Fan Q
Nephrol Dial Transplant; 2015 Jun; 30(6):957-69. PubMed ID: 25646018
[TBL] [Abstract][Full Text] [Related]
18. Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signalling.
Ha TS; Hong EJ; Han GD
Diabetes Metab Res Rev; 2015 Jan; 31(1):50-60. PubMed ID: 24846128
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
